Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany

被引:110
|
作者
Beutin, L [1 ]
Zimmermann, S [1 ]
Gleier, K [1 ]
机构
[1] Robert Koch Inst, Abt Mikrobiol, D-13353 Berlin, Germany
关键词
D O I
10.3201/eid0404.980415
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated different types of Shiga toxin-producing Escherichia coli (STEC) not belonging to serogroup O157 for their role as human pathogens. Non-O157 STEC isolated from 89 human patients in Germany were characterized according to serotypes, virulence markers, and association with human illness. EaeA-positive STEC were isolated from 54 (60.7%) of the patients and were frequently associated with severe diarrheal disease, hemolytic uremic syndrome, and young age. EaeA-negative STEC were found in 35 (39.3%) of the patients and were more associated with clinically uncomplicated cases and adult patients. For pediatric patients, a serotype-independent diagnosis of STEC is recommended.
引用
收藏
页码:635 / 639
页数:5
相关论文
共 50 条
  • [1] Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013
    Byrne, Lisa
    Vanstone, Gemma L.
    Perry, Neil T.
    Launders, Naomi
    Adak, Goutam K.
    Godbole, Gauri
    Grant, Kathie A.
    Smith, Robin
    Jenkins, Claire
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 1181 - 1188
  • [2] Whole Genome Sequencing for Public Health Surveillance of Shiga Toxin-Producing Escherichia coli Other than Serogroup O157
    Chattaway, Marie A.
    Dallman, Timothy J.
    Gentle, Amy
    Wright, Michael J.
    Long, Sophie E.
    Ashton, Philip M.
    Perry, Neil T.
    Jenkins, Claire
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [3] The emerging importance of Shiga toxin- producing Escherichia coli other than serogroup O157 in England
    Vishram, Bhavita
    Jenkins, Claire
    Greig, David R.
    Godbole, Gauri
    Carroll, Kevin
    Balasegaram, Sooria
    Byrne, Lisa
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (07)
  • [4] The epidemiology of Shiga toxin-producing Escherichia coli serogroup O157 in England, 2009-2019
    Butt, Saira
    Jenkins, Claire
    Godbole, Gauri
    Byrne, Lisa
    EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [5] Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157
    Havelaar, AH
    Van Duynhoven, YTHP
    Nauta, MJ
    Bouwknegt, M
    Heuvelink, AE
    De Wit, GA
    Nieuwenhuizen, MGM
    Van De Kar, NCA
    EPIDEMIOLOGY AND INFECTION, 2004, 132 (03): : 467 - 484
  • [6] The history and evolution of Escherichia coli O157 and other Shiga toxin-producing E. coli
    Derek Law
    World Journal of Microbiology and Biotechnology, 2000, 16 : 701 - 709
  • [7] The history and evolution of Escherichia coli O157 and other Shiga toxin-producing E. coli
    Law, D
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2000, 16 (8-9): : 701 - 709
  • [8] Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E-coli
    Law, D
    JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 (05) : 729 - 745
  • [9] Geographical association between livestock density and human Shiga toxin-producing Escherichia coli O157 infections
    Friesema, I. H. M.
    De Kassteele, J. Van
    De Jager, C. M.
    Heuvelink, A. E.
    Van Pelt, W.
    EPIDEMIOLOGY AND INFECTION, 2011, 139 (07): : 1081 - 1087
  • [10] Shiga toxin-producing Escherichia coli O157 associated with human infections in Switzerland, 2000-2009
    Kaeppeli, U.
    Haechler, H.
    Giezendanner, N.
    Cheasty, T.
    Stephan, R.
    EPIDEMIOLOGY AND INFECTION, 2011, 139 (07): : 1097 - 1104